17-N-Allylamino-17-demethoxygeldanamycin: Difference between revisions

Jump to navigation Jump to search
m (Protected "17-N-Allylamino-17-demethoxygeldanamycin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
 
Line 25: Line 25:
}}
}}
{{SI}}
{{SI}}
{{EH}}
 


'''17-N-Allylamino-17-demethoxygeldanamycin''' is a substance that is being studied in the treatment of  [[cancer]], specific young patients with certain types of [[leukemia]] or solid [[tumors]], especially [[kidney]] [[tumors]]. As of June [[2005]], 17-N-allylamino-17-demethoxygeldanamycin is undergoing Phase 1 and Phase 2 [[clinical trials]]. It belongs to the family of [[medication|drugs]] called [[antineoplastic|antitumor antibiotic]]s.
'''17-N-Allylamino-17-demethoxygeldanamycin''' is a substance that is being studied in the treatment of  [[cancer]], specific young patients with certain types of [[leukemia]] or solid [[tumors]], especially [[kidney]] [[tumors]]. As of June [[2005]], 17-N-allylamino-17-demethoxygeldanamycin is undergoing Phase 1 and Phase 2 [[clinical trials]]. It belongs to the family of [[medication|drugs]] called [[antineoplastic|antitumor antibiotic]]s.
Line 44: Line 44:
[[Category:Quinones]]
[[Category:Quinones]]


{{SIB}}
 


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 18:50, 8 August 2012

Template:Chembox new

WikiDoc Resources for 17-N-Allylamino-17-demethoxygeldanamycin

Articles

Most recent articles on 17-N-Allylamino-17-demethoxygeldanamycin

Most cited articles on 17-N-Allylamino-17-demethoxygeldanamycin

Review articles on 17-N-Allylamino-17-demethoxygeldanamycin

Articles on 17-N-Allylamino-17-demethoxygeldanamycin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on 17-N-Allylamino-17-demethoxygeldanamycin

Images of 17-N-Allylamino-17-demethoxygeldanamycin

Photos of 17-N-Allylamino-17-demethoxygeldanamycin

Podcasts & MP3s on 17-N-Allylamino-17-demethoxygeldanamycin

Videos on 17-N-Allylamino-17-demethoxygeldanamycin

Evidence Based Medicine

Cochrane Collaboration on 17-N-Allylamino-17-demethoxygeldanamycin

Bandolier on 17-N-Allylamino-17-demethoxygeldanamycin

TRIP on 17-N-Allylamino-17-demethoxygeldanamycin

Clinical Trials

Ongoing Trials on 17-N-Allylamino-17-demethoxygeldanamycin at Clinical Trials.gov

Trial results on 17-N-Allylamino-17-demethoxygeldanamycin

Clinical Trials on 17-N-Allylamino-17-demethoxygeldanamycin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on 17-N-Allylamino-17-demethoxygeldanamycin

NICE Guidance on 17-N-Allylamino-17-demethoxygeldanamycin

NHS PRODIGY Guidance

FDA on 17-N-Allylamino-17-demethoxygeldanamycin

CDC on 17-N-Allylamino-17-demethoxygeldanamycin

Books

Books on 17-N-Allylamino-17-demethoxygeldanamycin

News

17-N-Allylamino-17-demethoxygeldanamycin in the news

Be alerted to news on 17-N-Allylamino-17-demethoxygeldanamycin

News trends on 17-N-Allylamino-17-demethoxygeldanamycin

Commentary

Blogs on 17-N-Allylamino-17-demethoxygeldanamycin

Definitions

Definitions of 17-N-Allylamino-17-demethoxygeldanamycin

Patient Resources / Community

Patient resources on 17-N-Allylamino-17-demethoxygeldanamycin

Discussion groups on 17-N-Allylamino-17-demethoxygeldanamycin

Patient Handouts on 17-N-Allylamino-17-demethoxygeldanamycin

Directions to Hospitals Treating 17-N-Allylamino-17-demethoxygeldanamycin

Risk calculators and risk factors for 17-N-Allylamino-17-demethoxygeldanamycin

Healthcare Provider Resources

Symptoms of 17-N-Allylamino-17-demethoxygeldanamycin

Causes & Risk Factors for 17-N-Allylamino-17-demethoxygeldanamycin

Diagnostic studies for 17-N-Allylamino-17-demethoxygeldanamycin

Treatment of 17-N-Allylamino-17-demethoxygeldanamycin

Continuing Medical Education (CME)

CME Programs on 17-N-Allylamino-17-demethoxygeldanamycin

International

17-N-Allylamino-17-demethoxygeldanamycin en Espanol

17-N-Allylamino-17-demethoxygeldanamycin en Francais

Business

17-N-Allylamino-17-demethoxygeldanamycin in the Marketplace

Patents on 17-N-Allylamino-17-demethoxygeldanamycin

Experimental / Informatics

List of terms related to 17-N-Allylamino-17-demethoxygeldanamycin


17-N-Allylamino-17-demethoxygeldanamycin is a substance that is being studied in the treatment of cancer, specific young patients with certain types of leukemia or solid tumors, especially kidney tumors. As of June 2005, 17-N-allylamino-17-demethoxygeldanamycin is undergoing Phase 1 and Phase 2 clinical trials. It belongs to the family of drugs called antitumor antibiotics.

References


External links


Template:WH Template:WS